|
|
- Levi Garraway, MD, PhD
- Title: Associate Professor of Medicine, Harvard Medical School
- Institution: Dana-Farber Cancer Institute
- Research: Hypothesis that the spectrum of resistance mechanisms for any given cancer therapeutic modality could coalesce onto a much smaller set of critical downstream effect or “nodes.” Focus on discerning the mechanisms operating within these “points of coalescence” to yield new insights into oncogenic dependencies and illuminate guiding principles for the design of novel therapeutic combinations.
|
